We studied the epidemiology, microbiology, clinical aspects and outcome of bloodstream infections (BSI) in a tertiary paediatric intensive care unit. All BSI episodes were prospectively identified and analysed. The paediatric intensive care unit moved in 2006 from an open-plan unit to a new (all single room) unit. Three hundred and fifty-three BSI episodes occurred in 299 of 4162 patients. Overall, BSI incidence was 85 per 1000 hospitalised children. Fewer BSI episodes occurred during the last two years of the study ((70 of 1061 admissions, 6.5% versus 283 of 3101 admissions, 9.1%, respectively, P=0.01). There were 127 of 340 (37.4%) community-acquired and 213 of 340 (62.6%) nosocomial BSI episodes (31 of 1000 and 51 of 1000, respectively). Nosocomial BSI episodes decreased during 2007 to 2008 versus 2000 to 2006 (37.7% versus 55.8%, P=0.03). In 448 instances, pathogens were isolated, 231 (52%) Grampositive and 188 (42%) Gram-negative. Coagulase-negative Staphylococci, S. pneumoniae and S. aureus (41.1%, 19.9% and 11.7%, respectively) were the most common Gram-positive and Enterobacteriaceae spp. the most frequent Gram-negative organisms (45.2%, of them Klebsiella spp. and E. coli 40% and 29.4%, respectively). A significant decrease was recorded during 2007 to 2008 in Enterobacteriaceae resistance to piperacillin, gentamicin and ciprofloxacin. Thirty of 299 (10%, 9 with S. pneumoniae-BSI) patients died. A significant decrease in BSI and nosocomial incidence and Enterobacteriaceae spp. antibiotic resistance was recorded following the conversion of the paediatric intensive care unit from an open ward to an all isolated rooms environment.
Impact of conversion from an open ward design paediatric
intensive care unit environment to all isolated rooms environment on incidence of bloodstream infections and antibiotic resistance in Southern Israel (2000 to 2008) Bloodstream infections (BSIs) are second in frequency after lower respiratory infections, as a cause of morbidity and mortality in intensive care units (ICUs) 1, 2 . The epidemiology of BSIs and their outcome in children differ from those in adults. While most paediatric studies have focused on outcomes of bacteraemia in the neonatal ICU [3] [4] [5] , paediatric ICU (PICU) patients represent a separate, more heterogeneous population with distinctly variable underlying disease processes and unique BSI microbiology [6] [7] [8] .
Nosocomial infections are a frequent problem in ICUs 9,10 . In Europe, the incidence of nosocomial infections ranges from 1% in general paediatric wards up to 23.6% in PICUs 11 . BSIs are the most common nosocomial infection in PICUs, reaching 28% to 52% of all these infections [11] [12] [13] [14] [15] .
While Gram-positive organisms represent the most frequently isolated pathogens, the problem of increasing antibiotic resistance of Enterobacteriaceae spp. in the PICU is worrying 7, 10, 14, 16, 17 . Furthermore, fungal BSIs are recorded with increasing frequency, reaching around 20% of all PICU BSI 10, 14 .
In Southern Israel, Frank et al found, between 1992 and 2002, an incidence of 24.1 episodes per 1000 patients in PICU, compared with only 1 per 1000 episodes among children admitted to the paediatric wards 18 . Levy et al 19 studied 375 Gram-negative paediatric BSIs occurring in a tertiary hospital in central Israel and showed that 43% occurred in infants <2 years of age and 47% were nosocomial. Klebsiella pneumoniae represented the most common pathogen in Gram-negative BSI and the resistance rates of nosocomial K. pneumoniae and Enterobacter spp. to second-and thirdgeneration cephalosporins reached 44% to 77% 19 .
The purpose of this study was to describe the epidemiologic and microbiologic features and outcome of BSI in PICU in Southern Israel during 2000 to 2008. The last two years of this period were characterised by the move of PICU to a new location, with a major impact on patient care and infection control management. As part of a quality improvement and infection control process, we investigated all BSI episodes that occurred in our PICU during the years preceding the change (2000 to 2006, six full years) and those following the move to the new location (2007 to 2008, two full years).
Methods
The Soroka University Medical Center is the only tertiarycare medical centre in southern Israel and served a population of around 800,000 inhabitants (of them around 250,000 children) during 2011. The hospital's PICU is a multidisciplinary medical/surgical unit admitting a wide range of diseases, including trauma and surgical emergencies, medical emergencies, burns, post surgical follow-up, malignancies and others. The PICU moved at the end of 2006 from a crowded six-bed, open single spaced room unit to a new, modern and infection control-oriented eight-bed unit, where patients are taken care of in individual rooms. Patients lie in private rooms equipped with individual sinks and antiseptic lotion and also cabinets for patients' most frequently used treatment equipment (syringes, needles, wound dressing care, diapers etc.), including readily available disposable gloves and gowns. This equipment is trashed with discharge from PICU and the room is disinfected by a special team. No major changes in medical equipment occurred during the study period (for example, the same central venous line [CVL] brands and same urinary catheters continued to be in use). The hospital's intravenous lines (including CVLs) local care changed from gauze dressing to transparent dressing in 2006. Ultrasound was not used for CVL placement and CVL insertion bundles. CVL location was changed according to clinical need of the patient (suspected line infection or other complication). No other major changes in infection control and antibiotic prescribing practices were recorded during 2007 to 2008. Use of home CVLs was a standard management policy during all the study years.
All clinically significant BSI episodes occurring in children aged one month to 15 years were prospectively recorded from the microbiology laboratory records. Additional epidemiological/clinical data were obtained from patients' medical charts and stored on a computerised database. The study was approved by the Ethics Committee of the Soroka University Medical Center (approval number 10272).
Nosocomial BSI was diagnosed when a clinically significant positive blood culture was drawn from a patient at any time after the first 48 hours of hospitalisation and if there was no evidence that the infection was present or incubating at the time of PICU admission. Isolation from two or more cultures drawn on separate occasions was required in immunocompetent patients presenting with fever or other clinical signs and symptoms when the pathogen was a potential skin contaminant (coagulase-negative Staphylococcus [CoNS], diphtheroids, Micrococci etc.). Microorganisms causing BSI were isolated using routine blood culture methods and their antibiotic susceptibility profiles determined in accordance with the National Committee for Clinical Laboratory standards recommendations 20 . Our PICU standard empiric antibiotic treatment protocol for patients with suspected BSI consisted of piperacillin/tazobactam plus amikacin during the study period.
Statistics
Data were computerised and analysed with the SPSS 16.0 package (IBM, Armonk, NY, USA). Analysis of variance and Student's t-tests were used to compare continuous variables. The chi-square test was used for univariate analysis of contingency tables. P-values of <0.05 were considered statistically significant.
Results
Overall, 4162 patients were admitted to the PICU. A total of 353 BSI episodes occurred in 299 infants and children (8.5% of the patients admitted to PICU between 2000 and 2008); there were 283 (80.2%) BSI episodes (occurring in 244 patients) between 2000 and 2006 and 70 (19.8%) between 2007 and 2008 (occurring in 55 patients). Two hundred and fifty-nine (86.6%) patients had one BSI episode, 28 had two episodes, ten had three episodes and two had four BSI episodes. Two hundred and nine (59.2%) episodes occurred in males. There were 266 (75.3%) Bedouin Muslim and 87 (24.7%) Jewish patients. One hundred and twenty-eight (36.9%) episodes occurred in children aged between one and twelve months, 131 (37.8%) in children aged between 13 and 48 months, 36 (10.3%) in children aged 49 months to ten years and 52 (15%) in children older than ten years. The overall incidence of BSI was 85 episodes per 1000 children admitted to PICU. Fewer BSI episodes occurred during the last two years of the study (2007 and 2008), compared with 2000 to 2006 (70 of 1061 admissions, 6.5% versus 283 of 3101, 9.1%, respectively, P=0.01, odds ratio=1.42:1.07 to 1.88). There was a peak of 111 episodes in 1000 children during 2002 and a nadir of 56 episodes in 1000 children during 2008 ( Figure 1 ).
Medical background
One hundred and fourteen patients (38%) developed BSI without evidence of any previous medical condition. Among the 185 patients with previous diseases/conditions, congenital heart defects (18% of all patients), respiratory pathologies (18%), gastrointestinal disorders (9%), failure to thrive (8%), central nervous system pathologies (6%) and malignancies (5%) represented the most prevalent predisposing conditions. Twenty-two patients (7%) were receiving home intravascular treatments through a central venous catheter at the time of BSI diagnosis. 
Associated clinical diagnoses

Microbiology
Four hundred and forty-eight pathogens were recovered in 353 BSI episodes (Table 1) . One pathogen was isolated in 283 episodes (81.8%), two in 43 (12.2%), three in 16 (4.5%) and greater than or equal to four pathogens in five BSI episodes (1.4%). Gram-positive pathogens, Gram-negative pathogens and fungi represented 52%, 42% and 6% of all isolates, respectively. CoNS, Streptococcus pneumoniae, K. pneumoniae, Pseudomonas spp., Acinetobacter spp., Staphylococcus aureus and Candida spp. were the most commonly isolated organisms (21.2%, 10.2%, 7.5%, 7.2%, 6.2%, 6% and 6% of all pathogens, respectively). CoNS, S. pneumoniae and S. aureus (41.1%, 19.9% and 11.7%, respectively) were the most common Gram-positive bacteria. Enterobacteriaceae spp. represented the most frequent Gram-negative pathogens (85/188, 45.2% of all Gramnegative isolates); of them, Klebsiella spp. and E. coli (40% and 29%, respectively) were the most common. Pseudomonas spp. and Candida spp. were recovered more frequently in nosocomial than in community-acquired BSI (10.6% versus 2.3%, P=0.001 and 10.6% versus 0.6%, P <0.001); S. pneumoniae was isolated more frequently in community-acquired BSI (20.5% versus 4.1%, P <0.001).
Community-acquired and nosocomial BSI
No significant differences were recorded in the distribution of pathogens between the periods 2000 to 2006 and 2007 to 2008, in respect to Gram-positive and Gram-negative representation, nor among the specific pathogens' representation between the two time periods (Table 2 ).
Antibiotic susceptibility
Of the Gram-negative organisms studied, 35%, 28%, 22%, 19%, 19%, 15% and 13% were resistant to piperacillin, ceftriaxone, gentamicin, piperacillin/tazobactam, imipenem, ciprofloxacin and ceftazidime, respectively. K. pneumoniae resistance rates to piperacillin, gentamicin and piperacillin/ tazobactam were 45%, 24% and 17%, respectively; none of the eight isolates studied was resistant to imipenem (Table 3) .
A significant decrease in the resistance rates of Enterobacteriaceae spp. to piperacillin, gentamicin and ciprofloxacin was recorded during 2007 to 2008, compared with 2000 to 2006 (Figure 1 ). Overall resistance rates of S. aureus to cloxacillin and clindamycin were 11% (one of nine isolates studied) and 4% (one of 26), respectively. There were four methicillin-resistant S. aureus (MRSA) isolates.
Streptococcus pneumoniae caused 46 BSIs, 36 during 2000 to 2006 and 12 during 2007 to 2008. The serotypes 6A (11%), 23F (11%), 1 (8%) and 19F (8%) were the most frequently isolated ones; 7, 10 and 13-valent pneumococcal conjugate vaccine serotypes were isolated in 16 of 46 (34.8%), 20 of 46 (43%) and 26 of 46 (56%) cases respectively. The minimal inhibitory concentration (MIC) to penicillin and ceftriaxone was determined in 17 of 46 (36.9%) pneumococcal isolates; two isolates had a penicillin minimal inhibitory concentration >2.0 µg/ml.
The number of patients hospitalised in PICU increased steadily each year from 2000 (403 cases) to 2008 (557 cases) ( Table 4 ). Of the 448 pathogens isolated, no significant increasing or decreasing trends in the distribution of the main Gram-negative, Gram-positive or fungal organisms were recorded during the study period.
Mortality
Overall fatality rate directly related to BSI was 10% ( Staphylococcus aureus 4 (10) 5 (11) 5 (11) 2 (4) 4 (9) 2 (4) 2 (5) 3 (6) 0 27
Candida spp. 2 (5) 1 (2) 4 (9) 6 (13) 5 (11) 2 (4) 5 (12) 2 (4) 2 (4) 29
In parentheses: number of episodes of bloodstream infection per 1000 children <18 years of age admitted to paediatric intensive care unit.
Discussion
The present study summarises the main epidemiologic and microbiologic data on the BSI recorded at the PICU of the Soroka University Medical Center during the years 2000 to 2008, with particular emphasis on the effect (on the incidence and microbiologic characteristics of the disease) of the PICU transfer to a new location during the last period of the study (2006 to 2008) . We found in the present study that: 1) overall and nosocomial BSI incidence and Enterobacteriaceae spp. nonsusceptibility rates to antibiotics decreased significantly with the move of the unit to a new modern and infection control-oriented location; 2) Gram-positive organisms represented the most commonly isolated pathogens; 3) Enterobacteriaceae spp. were the most frequent Gram-negative and CoNS the most frequent Gram-positive pathogens causing BSI; 4) no differences were recorded in Enterobacteriaceae spp, CoNS and S. aureus distribution between community-acquired and nosocomial BSI; 5) the resistance rates of Klebsiella spp. to piperacillin/tazobactam and gentamicin and of Acinetobacter spp. to all antibiotics commonly used in PICU were high and of major concern.
Most of the published literature on BSI in the PICU focuses on nosocomial infections, while data on PICUcommunity-acquired BSI are limited. Lashimi et al described 285 nosocomial BSI episodes during 2003 to 2004 and found an incidence of 31.2 per 1000 hospitalisation days 14 .
In a study performed at our PICU during 1990 to 1999, Krontal et al 21 described 228 BSI episodes (128 nosocomial) and showed a significant increase in nosocomial BSI, together with an increase in the antibiotic resistance rates of Enterobacteriaceae spp. In central Israel, Grisaru-Soen 22 found a nosocomial BSI incidence of 65 per 1000 patients in PICU during 2000 to 2002. We report in the present study an incidence of 85 BSI cases per 1000 hospitalised children; of them 51 per 1000 were nosocomial.
We found a significant decrease in BSI incidence following the move of the unit to a new location and its conversion from a crowded, single-space room to new, spacious, all isolated individual rooms, facilitating optimal isolation and infection control. This was most probably due to a significant decrease in the nosocomial infections, because we could not record any other major changes in infection control and antibiotic prescribing practices during 2007 to 2008. Understaffing, close contact between patients and parents and crowding were found as major facilitators for nosocomial infection development in PICU 10 . Ben-Abraham et al 23 examined the effect of use of individual rooms on prevention of nosocomial infections and compared retrospective data from 1992 (when the PICU worked as an open single-space unit) with prospective surveillance from 1995 (when PICU moved to individual rooms). Although no changes in staffing, therapeutic protocols or infection control procedures were reported, a significant decrease in the average number of nosocomial infections per patient, as well as of respiratory, urinary and catheter-related infections and length-of-stay in the PICU were found 23 .
We consider that the decrease in overall BSI rates and also in nosocomial BSI rates recorded during the last two years of the study was indeed related to the improved infection control practices made possible by the move, although the time period analysed was too short and a prospective and longer follow-up period is definitely needed in order to confirm these findings.
The reported overall rates of BSI and of nosocomial BSI episodes in our PICU as well as the finding that the majority of BSIs were nosocomial are similar to previous reports from Israel 22 . However, the rates of nosocomial BSI during the study period were significantly higher than those described previously 18 . The main risk factors for development of nosocomial BSI in PICU include use of venous and arterial catheters, administration of parenteral nutrition, dialysis, invasive procedures or transport out of the PICU 24 . In the United States, the number of days of use of central catheters, erythrocyte transfusion and the presence of genetic syndromes represented significant risk factors for BSI occurrence 24 .
CoNS, S. pneumoniae and S. aureus were the most frequently isolated Gram-positive organisms, while Enterobacteriaceae spp. represented around half of the Gram-negative organisms. The presence of S. pneumoniae, on one hand, and of Enterobacteriaceae spp. and Pseudomonas spp. on the other hand, as the main pathogens causing community-acquired and nosocomial BSI, respectively, is not surprising, according to previous data from our hospital 18, 25 . However, the emergence of CoNS and Acinetobacter spp. as important pathogens in communityacquired BSI reached higher rates than previously reported 18, 26 . The percentage of S. aureus among communityacquired BSI pathogens was relatively low (5.2%) and no isolation of MRSA was reported in community-acquired BSI. These findings are different to previously reported data 26 showing high (65.2%) rates of MRSA isolation in PICU in Taiwan. Creel et al reported 11 cases of severe communityacquired MRSA infections leading to hospitalisation at PICU, with a 27% mortality rate 27 .
CoNS was the most common BSI pathogen; it was the most common Gram-positive pathogen causing nosocomial BSI and the second in frequency among the Gram-positive microorganisms causing community-acquired BSI. The approach at our PICU in order to determine if its recovery represented a true infection or contamination was in accordance with Centers for Disease Control and Prevention guidelines, requiring, in immunocompetent patients, at least two positive blood cultures from two different venepuncture sites 28 .
Of the 48 BSI S. pneumoniae isolates, 7-valent pneumococcal conjugate vaccine serotypes were present in only 35% of the BSI episodes, a lower percentage compared with 70% to 90% previously reported in Europe and the United States 30 , but similar to data recently reported from Israel 31 , where the reported proportion of the 7-valent pneumococcal conjugate vaccine serotypes plus the additional 6A serotype isolated in invasive pneumococcal disease in children <5 years during the pre-vaccine period (2004 to 2009) was only 60.4%.
We report relatively high (15% to 22%) nonsusceptibility rates to piperacillin-tazobactam and ciprofloxacin of the Gram-negative organisms causing BSI; in addition, the nonsusceptibility rates to gentamicin of K. pneumoniae and Acinetobacter spp. (22% and 40%) were high. On the other hand, the move of the PICU to a new location was accompanied by a significant decrease in the nonsusceptibility rates of Enterobacteriaceae spp. to piperacillin, gentamicin and ciprofloxacin, most probably related to better implementation of infection control practices.
The mortality rates from BSI at PICU reached 10% and were similar to previous data from Israel (11% to 18.9%) 18, 19 . However, these rates were lower compared with the mortality rates from BSI in adult ICUs, reported to reach 50% 32, 33 . The most common pathogen related to mortality in our series was S. pneumoniae.
The main limitations of this study are related to being conducted in a single medical centre and its retrospective data collection. In addition, the second part of the study (2007 to 2008) was conducted in a relatively short period of time and its conclusions on the reduction in the incidence of BSIs should be consolidated with a longer follow-up.
Conclusion
In conclusion, we showed a significant decrease in the overall and also nosocomial BSI rates at the PICU following the move of the unit to a new location and its conversion from an open ward design environment to an all isolated rooms environment. Our study confirms previous data establishing Enterobacteriaceae spp. and CoNS as the most frequently isolated Gram-negative and Gram-positive organisms causing BSI at PICU. The high antibiotic nonsusceptibility rates of Enterobacteriaceae spp. and Acinetobacter spp. are of concern and have to be taken in consideration when deciding on the appropriate antibiotic policy at PICU.
